R & S Northeast

What R & S Northeast does

R&S Northeast, LLC is a family-owned pharmaceutical wholesaler founded in 1973 and headquartered in Fountain Run, Kentucky, with a distribution center in Philadelphia, Pennsylvania, and an additional office in Pulaski, Tennessee. The company distributes brand, generic, and over-the-counter pharmaceuticals as well as medical and surgical supplies to 340B entities, independent and hospital pharmacies, hospitals and healthcare facilities, EMS services, animal health organizations, and city/state/local public health departments across all 50 U.S. states. Sourcing is 97% direct from manufacturers, enabling GPO-equivalent or direct-source pricing under flexible, customized multi-year contracts.

The company's technology stack centers on three interconnected web platforms: CMAPP (signup.rsnortheast.com), a self-service customer onboarding and account-approval application; the RNS Store (store.rsnortheast.com), an authenticated electronic ordering portal for placing orders, viewing invoices, and managing recurring orders; and an external DSCSA trace-and-trace portal (rs-dscsa-portal.track-n-trace.net) that supports Drug Supply Chain Security Act serialization, traceability, and authentication requirements. Additional integrations include Express222 for electronic DEA Schedule 222 controlled-substance ordering and the GS1 US Data Hub for GLN acquisition. The company holds NABP Verified-Accredited Wholesale Distributor (VAWD) accreditation, is a Healthcare Distribution Alliance member, and operates under full DSCSA compliance.

R&S monetizes primarily through transaction-fee resale of pharmaceuticals and medical supplies at GPO or direct-source pricing, supplemented by 340B administration services that channel discounted outpatient drug pricing to eligible entities. Distribution is conducted via an inside-sales model (toll-free phone, SMS, and electronic portal) supported by a national distribution network shipping from Philadelphia, with named account representatives (Jami, Danielle, Shannon, Michele, Tina) providing relationship-based service. Go-to-market combines inside sales for SMB/long-tail accounts with field/enterprise sales targeting hospitals, 340B entities, large health systems, and government public-health customers. Customer segments are diversified across healthcare, nonprofit/NGO, education, and government verticals, with no single dominant account evident in the data.

Name

R & S Northeast

Legal name

R&S Northeast, LLC.

Website

https://rsnortheast.com

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

101–250 employees

Short description

R&S Northeast is a family-owned pharmaceutical wholesaler, founded in 1973 and headquartered in Fountain Run, KY, distributing brand, generic, and OTC pharmaceuticals plus medical supplies to 340B entities, pharmacies, hospitals, EMS, animal health, and public-health customers across all 50 U.S. states.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

akta.pro secondary industries

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical distribution
• Pharmaceutical wholesale
• 340B administration
• Medical supply distribution
• DSCSA compliance

Headquarters

HQ city

Fountain Run

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical and Medical Supply Distribution: Core revenue from resale of brand, generic, and OTC pharmaceuticals plus medical/surgical supplies at GPO or direct-source pricing across all 50 U.S. states. Pricing is quote-/contract-based with flexible contract terms.
2. 340B Administration Services: Revenue from providing 340B program access that delivers discounted outpatient drug pricing to eligible entities (340B pharmacies, hospitals, clinics), creating transaction volume at reduced-but-guaranteed margins.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

R&S Northeast is a wholesale pharmaceutical and medical supply distributor that delivers brand, generic, and OTC pharmaceuticals plus medical and surgical supplies to 340B entities, independent and hospital pharmacies, EMS services, hospitals, animal health organizations, and government public health services across all 50 U.S. states. The company supports its distribution operations with DSCSA-compliant serialization and traceability, a 340B administration service, GPO or direct-source pricing with flexible contracts, cold-chain-capable shipping, and online ordering via the proprietary RNS Store and CMAPP customer-onboarding portal.

Product overview

R&S Northeast, LLC. operates a single integrated pharmaceutical distribution business centered on a core wholesale-distribution offering (brand, generic, and cold-chain pharmaceutical plus medical/surgical supplies) that is delivered through three interconnected platforms: CMAPP (the customer onboarding and account-management web application at signup.rsnortheast.com), the RNS Store / Electronic Ordering System (the authenticated ordering portal at store.rsnortheast.com), and an external DSCSA Portal (rs-dscsa-portal.track-n-trace.net) for supply-chain traceability. Layered onto this platform-plus-distribution architecture are several service modules — 340B Administration, GPO/Direct-Source Sourcing with flexible contract terms, Animal Health and EMS Emerging-Markets distribution, and value-added DSCSA compliance support — which together form the company's vertically integrated pharmaceutical-services portfolio for 340B entities, pharmacies, hospitals, EMS providers, public-health services, and animal health organizations across all 50 U.S. states.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Distribution (Brand & Generic Pharmaceuticals, Medical/Surgical Supplies) Core wholesale distribution offering delivering brand and generic pharmaceuticals plus medical and surgical supplies to 340B entities, pharmacies, EMS services, hospitals, and animal health organizations across all 50 U.S. states. Licensed and DSCSA-compliant, with GPO or direct-source pricing and cold-chain-capable shipping.
• 340B Administration Value-added service providing 340B-covered entities with access to discounted outpatient drug pricing to lower acquisition costs, supported by R&S Northeast's contract terms and account-management team.
• DSCSA-Compliant Supply Chain & DSCSA Portal Full DSCSA-compliant distribution service including serialization, tracing, and authentication of prescription drug products, supported by an external DSCSA Portal and resource documentation for GLN, EPCIS, and dispenser requirements.
• CMAPP (Customer Management Application & Application Portal) Web application at signup.rsnortheast.com used by prospective customers to register, submit required business documents (licenses, ship-to documentation), and apply for a new account. Once approved, customers gain full access to order-portal features such as online ordering, invoice viewing, and recurring orders.
• RNS Store (R&S Electronic Ordering System / Sales Portal) Authenticated web portal at store.rsnortheast.com for existing approved customers to place online pharmaceutical and medical-supply orders, view invoices, and manage recurring orders. Account registration is gated through CMAPP.
• GPO / Direct-Source Sourcing & Contract Services Procurement and contracting service offering customers flexible contract terms and competitive pricing via Group Purchasing Organizations (GPOs) or direct sourcing from manufacturers (97% of products are sourced direct from manufacturers).
• Animal Health, EMS, and Emerging Markets Distribution Specialty pharmaceutical and medical-supply distribution serving emerging-markets customer segments beyond traditional retail and hospital pharmacies, including animal health organizations and emergency medical services (EMS).

Quantifiable outcome

• Customer increased order placement by 50% after a 6-month evaluation trial.
• +4 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• National Association of Boards of Pharmacy (NABP)coreOthersNABP accredits R&S Northeast as a Verified-Accredited Wholesale Distributor (VAWD) and provides DSCSA reference resources. The NABP logo is displayed on the website as a trust signal.
• GS1 UScoreTechnology or IntegrationR&S Northeast links to the GS1 US Data Hub and promotes GLN (Global Location Number) acquisition for customers. GS1 standards underpin R&S's DSCSA-compliant serialization and traceability infrastructure.
• Healthcare Distribution Alliance (HDA)minorOthersR&S Northeast displays the HDA Member logo, indicating membership in the pharmaceutical distribution industry's principal trade association.
• Express222coreTechnology or IntegrationIntegration that enables R&S Northeast customers to place DEA Schedule 222 controlled substance orders electronically through express222.com.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Rochester Drug Cooperative: Independent pharmacy-owned cooperative distributor serving independent pharmacies with competitive GPO pricing and personal service. Comparable mission and customer base to R&S.
• Morris & Dickson: Privately held pharmaceutical wholesaler with a similar independent, relationship-driven model serving retail and hospital pharmacies. Closely comparable in size, ownership profile, and customer mix.
• KeySource Medical: Specialty distributor focused on physician offices, clinics, and 340B entities with brand and generic pharmaceuticals. Comparable niche mid-market distributor with similar inside-sales and 340B positioning.
• Smith Drug Company: Independent regional pharmaceutical wholesaler serving independent pharmacies across the U.S. with comparable brand/generic distribution, DSCSA-compliant operations, and inside-sales service model.
• North Carolina Mutual Wholesale Drug Company: Independent wholesale drug cooperative serving independent pharmacies with branded and generic pharmaceuticals. Highly comparable mid-sized competitor with similar customer-centric model.
• H.D. Smith (now part of Cardinal Health): Was a major independent U.S. drug wholesaler serving independent pharmacies, hospitals, and 340B entities — directly comparable business model before acquisition by Cardinal Health. Illustrates the consolidation path facing independents.
• Anda Inc (Teva): U.S. distributor of generic, brand, and specialty pharmaceuticals serving retail pharmacies, hospitals, and alternate-care sites. Directly comparable in product breadth and customer segments.

Broad incumbents

• McKesson Corporation: Largest U.S. pharmaceutical distributor serving the full spectrum of retail, hospital, and 340B customers. Compares to R&S as the dominant scaled incumbent against which R&S competes for both suppliers and buyers.
• Cencora (formerly AmerisourceBergen): Top-3 U.S. pharma wholesaler with deep specialty, animal health, and 340B capabilities. Directly comparable as a broad-line incumbent competing for the same hospital, pharmacy, and government customers.
• Cardinal Health: Top-3 U.S. pharmaceutical distributor with strong retail pharmacy and hospital franchises. Comparable as a large incumbent setting the pricing and service benchmarks R&S must meet or differentiate against.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/rsnortheastllc
• LinkedInlinkedin.com/company/r-&-s-northeast
• Instagraminstagram.com/rsnortheast/?hl=en

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about R & S Northeast